Marquee healthcare investor OrbiMed is finalising about $40-million investment in Kolkata-based Suraksha Diagnostics, which operates a chain specialising in pathology and radiology services across the national capital region (NCR), Bihar and West Bengal.  The funding will be utilized to expand the laboratory network and invest in equipment and the tech backbone.